Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1 Delta E9 mouse model of Alzheimer's disease

dc.contributor.authorToledo, E. M.
dc.contributor.authorInestrosa Cantín, Nibaldo
dc.date.accessioned2016-05-10T18:14:47Z
dc.date.available2016-05-10T18:14:47Z
dc.date.issued2010
dc.identifier.doi10.1038/mp.2009.72
dc.identifier.issn1359-4184
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/13426
dc.identifier.urihttps://doi.org/10.1038/mp.2009.72
dc.language.isoen
dc.relation.isformatofMolecular Psychiatry No. 3 (15), p. 272-285.
dc.revistaMolecular Psychiatryes_ES
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherCerebro - Enfermedadeses_ES
dc.subject.otherEnfermedad de Alzheimeres_ES
dc.subject.otherPéptido beta-Amiloidees_ES
dc.titleActivation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1 Delta E9 mouse model of Alzheimer's diseasees_ES
dc.typeartículo
sipa.codpersvinculados99331
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswePSEN1 Delta E9 mouse model of Alzheimer's disease.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description: